In a crossover clinical trial published in the European Journal of Lipid Science and Technology , investigators found that a chewable fish oil emulsion supplement may provide higher circulating levels of omega-3 fatty acids compared with a soft gel.
In the trial, 12 healthy adults took a single dose of 1.1 g eicosapentaenoic acid (EPA) plus docosahexaenoic acid (DHA) omega 3 fatty acids from fish oil, either as a chewable emulsion or as a soft-gel capsule, with a 1-week wash-out period between the 2 preparations.
The chewable format increased overall uptake of omega 3 fatty acids by 25% and boosted peak levels of EPA and DHA in the blood by 50%, while also reaching these peaks more rapidly.
"The findings strengthen the evidence that omega 3 emulsions provide faster and more efficient absorption than standard soft-gel capsules," said corresponding author Professor Renger Witkamp, PhD, from Wageningen University, in The Netherlands. "Because the study used a dose similar to what people normally take, these results are considered highly relevant."
URL upon publication: https://onlinelibrary.wiley.com/doi/10.1002/ejlt.70163
Additional Information